Abstract: A pliable container for a liquid inhalational anesthetic is disclosed. In various configurations, a pliable container comprises a pliable container body, a threaded spout, and a liquid inhalational anesthetic. The pliable container body can comprise a laminate, such as a laminate comprising at least one aluminum layer and at least one polymer layer. In some configurations, the liquid inhalational anesthetic can be in contact with a polymer layer. In some configurations, the liquid inhalational anesthetic can be in contact with an aluminum layer. In various configurations, a pliable container can further comprise a key collar, a cap, and a seal.

Abstract: A protective cover for a nasal cannula completely encloses the two prongs of the nasal cannula when properly installed. This protective cover will keep the nasal cannula from contacting potentially unclean surfaces when the nasal cannula is not in use. An optional UV light may be present in the protective cover to provide UV cleaning of the nasal cannula prongs when the cover is closed.

Abstract: Medical device packaging, medical device packaging assemblies, and methods for preparing and packaging medical devices. An example medical device packaging assembly may include a packaging pouch including a front pouch portion and a back pouch portion. The front pouch portion may include a first sheet of material having a plurality of layers. The back pouch portion may include a second sheet of material having a plurality of layers. A medical device may be disposed in the pouch. At least one of the plurality of layers of first sheet of material and the plurality of layers of second sheet of material may include a moisture scavenging layer. In addition, at least one of the plurality of layers of first sheet of material and the plurality of layers of second sheet of material may include a barrier layer that is configured to maintain the oxygen concentration within the packaging pouch.

Abstract: This invention provides a method of treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the patient laquinimod as an add-on therapy to or in combination with interferon-?. This invention also provides a package and a pharmaceutical composition comprising laquinimod and interferon-? for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with interferon-? in treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and interferon-? in the preparation of a combination for treating a patient afflicted with multiple sclerosis or presenting a clinically isolated syndrome.

Abstract: A packaging system for medical devices includes a elongate connector having a plurality of channels formed therein, and a first and a second tubular holder configured to form an assembly with an elongate, coiled medical device. The first and second tubular holders each have shapes congruous with the plurality of channels, and are positionable therein such that the elongate connector forms a bridge attaching the tubular holders in an assembly with a medical device.

Abstract: A substantially rigid defibrillator carrying case having a hinged side, a latch disposed on a latch side opposite the hinged side, and a handle disposed on a handle side disposed between the hinged side and the latch side. The carrying case is constructed without protrusions and with a rigid handle, which combine to allow easy removal and deployment of the contents from a vehicle storage location to a cardiac arrest patient. The carrying case is further constructed for greater ease of use during rescue, greater ro-bustness, and for ease of maintenance.

Abstract: An information holder for holding informational documents used to track and identify medical instruments can be releasably attached to a sterilization container or tray. The information holder includes an autoclavable material pouch and a releasable attachment structure coupled to the pouch for securing the information holder to sterilization container or tray. The attachment structure can include adhesive or a handle-engaging member. The information holder can be removed from the container or tray after sterilization without breaching the sterilization of the contents contained within sterilization container or tray. The information holder can be re-attached to the same or a different container.

Abstract: A method and an arrangement are disclosed for providing an implant for implantation in a body lumen, that include at least one processing unit (1) for processing the implant (7; 103), a sheathing (2) with a front opening (3) and a rear opening (4), which is at least partially disposed at or in the processing unit (1), and at least one power unit (5). The implant (7; 103) can be stored inside the sheathing (2) between the openings (3, 4). The power unit (5) serves for generation of a current (P) of a defined medium through the sheathing (2), which is connected at least to one opening (3; 4) of the sheathing (2), whereby the current (P) flows inside the sheathing (2) with the stent (7; 103).

Abstract: A multi-compartment container for the secure storage of therapeutic agents comprises at least a base portion having at least two cavities, said at least two cavities serving as the location where said therapeutic agents are stored, and a child resistant device. Said child resistant device allows for the secure storage of said therapeutic agents. Said child resistant device may be in the form of a typical prescription pill container cap or may be more complex, such as a combination lock. Other features may include covers to keep said therapeutic agents in place, hinges to open said multi-compartment container, and labels corresponding to related cycles for said therapeutic agents.

Abstract: The present invention relates to bags made from medical-grade paper for sterilization, with sterilization-process indicators and pigmented-adhesive-based safety features, which is easy to handle and use and can be used to store materials, more particularly surgical medical material, for sterilization. Such bags are produced using medical-grade paper that is treated on the surface thereof with a microbiocide for sterilization, and, owing to the structure and design thereof, allow safe, rapid handling of the sterilized material placed within, since there are visual indicators that guarantee the hermetic closure and sealing thereof. Furthermore, generally, the invention has printed indicators that change color depending on the sterilization process carried out on the bags and on whether said process was carried out correctly.

Abstract: A housing secures an intravenous fluid bag along a portion of a support pole. The intravenous bag is suspended inside the housing, which is formed from three molded parts. A molded back part and a molded end part are joined in a permanent manner along a seam line, and these molded parts define a majority of the housing. A molded door part completes the housing, the molded door part being hingedly attached to the molded back part, providing the housing with an open and a closed position. Aligned slots in the molded end part allow the support pole portion to pass through the housing interior when the housing is in the closed position, and at least one cradle, attached to the molded end part, secures the support pole portion. The molded door part can be latched when in the closed position.

Abstract: The invention relates mainly to a packaging which may be sterilized and/or depyroged. The invention relates in particular to a packaging for the sterilization or pyrogen free packaging for one or more packaged devices, said packaging comprising a valve or outlet tube.

Abstract: A pharmacutical composition for parenteral administration of a somatostatin analogue salt of aspartate, e.g. mono- or diaspartate, lactate, succinate, e.g. mono- or disuccinate, acetate, glutamate, e.g. mono- or diglutamate or citrate and water forming a gelling depot system after injection in contact with the body fluid.

Abstract: A detecting device packing tray is provided which prevents a detecting device from being contaminated and damaged. The detecting device packing tray includes a tray main body configured to support a detecting device including a detection region to detect a reaction result. The tray main body includes a non-contact groove provided at a position corresponding to the detection region of the detecting device when the detecting device is supported by the tray main body so that the detection region does not contact the tray main body.

Abstract: A sharps container for (i) safe transportation and dispensing of a large number of unused pen needle assemblies, and (ii) safe storage of used pen needle assemblies. The unused pen needle assemblies may be connected to a flexible tape and are removed from a storage receptacle via an exit opening in the receptacle.

Abstract: A package system for a medical device is disclosed. The package system may include a first part and a second part, where a holding platform can be incorporated into the first part of the package system and a collection tray can be incorporated into the second part of the package system. The first part may include leg portions. The leg portions of the first part can be folded and fitted into matching pockets of the second part, so that the first part of the package system can provided a relatively elevated and stable holding platform to hold the medical device. The package system can contain the medical device in the package system in a storage state, and hold the medical device with the holding platform in an application state.

Abstract: A topical wound treatment composition comprises a hydrogen peroxide generator; alkaline powder; not more than 5 percent by weight of water; additional topical active agent if desired, and emollient (preferably hygroscopic emollient) to balance. When topically applied to a wound and water from the surrounding environment diffuses into the composition, the hydrogen peroxide generator and/or the alkaline compound diffuse into one another, causing a chemical reaction that generates treatment-effective amounts of oxygen to occur. The oxygen can then diffuse out of the composition and aid in wound treatment or healing.

Abstract: A visually-coordinated absorbent product includes an absorbent article component including a garment side outer cover and a body side liner, wherein the article component has at least a first and second visual characteristic, and wherein the first visual characteristic is different from the second visual characteristic. The absorbent product also includes a first packaging component including at least first and second visual characteristics, wherein first and second visual characteristics of the absorbent article are coordinated to the first and second visual characteristics of the packaging component, and wherein at least a portion of one of the garment side outer cover and the body side liner is configured with the article component first visual characteristic and at least a portion of one of the garment side outer cover and the body side liner is configured with the article component second visual characteristic.

Abstract: A sterilized system component is disclosed for holding a container of neonate nutritional liquid during a warming of the nutritional liquid. Structurally, the system component includes a pouch-shaped receptacle having a water-filled enclosure. The receptacle includes an outer bag and an inner bag. The inner bag is conformed to be received into the outer bag with the open end of the inner bag affixed to the periphery of the outer bag opening to create a permanent, fluid-tight seal. This permanent seal then creates an enclosed fluid chamber between the inner bag and the outer bag that can be filled with warm water through a fluid port that is provided in the outer bag. Prior to the warming procedure, both the receptacle and the water that is used need are sterilized using ultraviolet radiation from a germicidal lamp.

Abstract: Provided is a medical kit with all the necessary components for a medical practitioner in the office practice setting to inject a variety of anesthetics. The kits can comprise a holder, such as a box, and active pharmaceutical ingredients (API), with each API placed in a separate container in a form that is ready for injection, the API selected from the group consisting of: a. lidocaine hydrochloride and triamcinolone acetonide with or without a separate container of ammonia; b. bupivacaine hydrochloride (HCl) and lidocaine hydrochloride (HCl), and optionally one or more of triamcinolone acetonide, methylprednisolone acetate, or dexamethasone sodium; c. bupivacaine hydrochloride (HCl) and one or more of triamcinolone acetonide or methylprednisolone acetate; d. Methylprednnisolone acetate and lidocaine hydrochloride (HCl), and optionally bupivacaine hydrochloride (HCl); e. methylprednisolone acetate and lidocaine hydrochloride (HCl), and bupivacaine hydrochloride (HCl); f.

Abstract: The present invention is drawn to compositions, systems, and methods of treating skin disease. The composition includes a peroxygen, a transition metal or alloy thereof, and optionally, an alcohol and/or a drug. The composition can be packaged as part of a two-part system, and in one example, the drug is acetylsalicylic acid.

Abstract: Multi-layered plastic polymeric container useful for the storage and conservation of pharmaceutical compositions, sterile or non sterile, which comprises an inner layer and an outer layer, a gas barrier layer, and adhesive layers.

Abstract: A catheter product package and method of forming same in which the package comprises a sheet material wrapped about the catheter product to form a package for the catheter product. The catheter product extends generally longitudinally within the package, and the sheet material extends from a point beyond the proximal end to a point beyond the distal end of the catheter product. The sheet material of the package is wrapped about the catheter product in a mariner defining confronting proximal end edges, confronting distal end edges, and confronting side edges. The confronting proximal end edges, distal end edges and side edges of the sheet material are joined by a seal after the sheet material is wrapped about the catheter product to define a sealed cavity. The sheet material has a tear strip affixed to it which causes the sheet material to tear along the tear strip to thereby cause the package to open along an intended opening line.

Abstract: A pre-filled, single-use, disposable medication chamber for use in a medical nebulizer system that delivers a mist of properly sized aerosol particles of medicament to the patient. The nebulizer can be effectively used in conjunction with conventional nebulizer cap, tee and mouthpiece devices that interface with the patient.

Abstract: A simple, low cost, efficient and stable micro-vial configuration for handling micro-volume of sample fluids. The interior wall geometry of the inventive vial is designed to include several axial sections of various interior diameters to provide a range of functionalities to address various design considerations. The interior wall defined in the vial has a cylindrical sample section, a wider cylindrical alignment section, a tapered or conical guide section, and a relatively large cylindrical body section, arranged in sequence in that order along the center axis of the vial. The sample section is designed to hold a small volume of a sample fluid, and to receive the tip end of a capillary tube. The alignment section has a larger diameter than the sample section, designed to receive a cylindrical support that coaxially supports the relatively fragile capillary tube. The tip of the capillary tube dips into the micro-volume of sample fluid held in the sample section.

Abstract: An apparatus and method for retaining medical instruments is disclosed. The apparatus includes a medical instrument tray having a substantially planar, rigid interior section, wherein the interior section has a plurality of holes formed therein. A flexible grommet sheet is positioned abutting a first side of the medical instrument tray, the flexible grommet sheet having a plurality of openings therein, wherein at least a portion of the plurality of openings are substantially axially aligned with the plurality of holes formed within the interior section. A substantially rigid back plate is removably attached to the medical instrument tray, wherein the flexible grommet sheet is positioned between the first side of the interior section and the back plate, and wherein the back plate has a plurality of holes positioned therein, wherein the plurality of holes are substantially axially aligned with the plurality of holes formed within the interior section.

Abstract: In the absorbent article package, display element unit that has display elements exhibiting a pattern and/or a mark and non-display element unit that does not have display elements are provided on a package sheet that encloses the absorbent article. A window unit, which is configured to allow the absorbent article packages contained therein to be seen, is formed on one side of a container bag and is configured so that only the non-display element unit can be seen through the window. A container bag display unit that shows the display elements is provided on the one side where the container bag window is provided.

Abstract: The evacuation system employs a piston to deliver fluid for irrigating and aspirating a body cavity, such as a bladder. A pivotal screen is disposed across the flow path of the fluid to move out of the fluid flow path during irrigation of the bladder and to move back into the flow path during aspiration of the bladder. The screen screens out particulate matter from the return flow for depositing into the container of the system.

Abstract: The present invention is directed to providing a sterile container protecting various surgical grafts, implants and devices from incidental contamination and damage during operative procedures. The design includes an inner box to contain the items, and an outer box to protect the exterior of the inner box from contamination in the event of fall or other contamination, such as from airborne particles or liquids, fall from the sterile field, or by non-sterile handling. In the event of fall or contamination of the outer box, the surgical staff will be able to recover the inner box and its contents in sterile and unspoiled condition without difficulty.

Abstract: A package for use with a beneficial agent delivery device. The package includes at least one filling chamber having a sealed penetrable access region, at least one compartment configured to hold a content, wherein the content includes at least one of a beneficial agent or a constituent of a beneficial agent, and at least one channel connecting the at least one filling chamber in fluid communication with the at least one compartment. At least a portion of the package is resealable to contain the content.

Abstract: The present invention is directed towards a method and apparatus for packaging or containing, handling and managing of a variety of materials or other contents from a variety of sources which encounter use under various dynamic applications, conditions and for a plurality of purposes. The invention more specifically is directed towards one or more containers or packages, suitably fitted or used for the handling or managing of materials or other contents along one or more cycles or chains of use.

Abstract: The present invention provides a microneedle patch container for effectively and hygienically securing a microneedle patch from manufacture to use. The container has a bottom surface recessed from the peripheral portion towards the centre, a side surface connected to the bottom surface and the peripheral portion, and a bottom-surface protruding portion protruding from the bottom surface. The flexible release-type sheet portion of the microneedle patch is secured to the protruding portion on the bottom surface. A lid can also be used which has a recessed portion pressing against the microneedle patch secured to the bottom-surface protruding portion of the container in the position corresponding to the bottom-surface protruding portion. This is preferably housed inside a pouch moulded from sterilised paper or sterilised film in order to keep the microneedle patch in an aseptic state.

Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, FORTEO® (recombinant human teriparatide), DULAGLUTIDE® (LY2189265), recombinant insulin glargine, RAMUCIRUMAB® (IMC-1121B), SOLANEZUMAB® (LY2062430), IXEKIZUMAB® (LY2439821), TABALUMAB® (LY2127399), NECITUMUMAB® (IMC-11F8), or CIXUTUMUMAB® (IMC-A12).

Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, LUCENTIS® (ranibizumab), BEXSERO® (meningococcal group B vaccine [rDNA, component, adsorbed]), AIN457 (secukinumab) or RELAXIN® (serelaxin).

Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine).

Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, Prolia® (denosumab), Xgeva® (denosumab), Aranesp® (darbepoetin alfa), AMG-145, romosozumab (AMG-785), ganitumab (AMG-479), trebananib (AMG-386), brodalumab (AMG-827), and rilotumumab (AMG-102).

Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, LYXUMIA (lixisenatide), LEMTRADA (alemtuzumab), REGN727/SAR236553 (alirocumab), SAR2405550/BSI-201 (iniparib), OTAMIXABAN (otamixaban), SARILUMAB (sarilumab), LANTUS and LYXUMIA (insulin glargine and lixisenatide) or VISAMERIN/MULSEVO (semuloparin sodium).

Abstract: A container storing an anesthetic is disclosed. The container is sealed by a closure and stores a liquid anesthetic solution. The anesthetic is from 0.1% to 10% by weight of the liquid anesthetic solution. The container is made of a material that is inert to the anesthetic and the closure is made of siliconized rubber or a metal. A concentration of the anesthetic in a liquid anesthetic solution stored in the container following a predetermined time period is at least 93% of a concentration of the anesthetic in a liquid anesthetic solution before the liquid anesthetic solution is stored in the container.

Abstract: Generally, packages for an analyte monitoring device are provided. The packages include a container for containing an analyte monitoring device. The container includes a bottom wall, a front wall, a rear wall, and two sidewalls extending from sides of the bottom wall to an open top end of the container. The front wall is shorter in height than the rear wall, and is on an opposite side of the bottom wall than the rear wall. The two sidewalls are on opposite sides of the bottom wall, and extend from the front wall to the rear wall. The package also includes an inner panel disposed between the front wall and the rear wall. A front compartment is formed between the inner panel and the front wall, and a rear compartment is formed between the inner panel and the rear wall. The opening of the rear compartment is at the top end of the container, and an opening of the front compartment is at the top end of the container. Analyte monitoring kits and methods relating thereto are also provided.

Abstract: A packaged kit for performing a photodynamic laser myringotomy includes a plurality of ear needles having different shaped absorbent applicators on distal ends of the needles, a vial of a single dose of an otologic formulation of mitomycin-C, a diluent carrier containing sterilized water, and a syringe. The component parts of the kit are used together to reconstitute the contents of the vial with the water in the diluent carrier, and then draw the reconstituted drug into the syringe. A selected one of the plurality of ear needles is then communicated with the syringe. The syringe and needle are then used to inject the reconstituted drug into the absorbent pad at the end of the needle, and the absorbent pad containing the drug is used to apply the drug to the tympanic membrane. The application of the drug to the tympanic membrane prepares the membrane for a myringotomy procedure, and in particular, a photodynamic laser myringotomy.

Abstract: Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications.

Abstract: A DNA vaccine suitable for eliciting an immune response against cancer cells comprises a DNA construct operably encoding a cancer-associated Inhibitor of Apoptosis-family protein and an immunoactive gene product, such as a cytokine or a ligand for a natural killer cell surface receptor, in a pharmaceutically acceptable carrier. A preferred cytokine is CCL21. Preferred ligands for a natural killer cell surface receptor include human MICA, human MICB, human ULBP1, human ULBP2, and human ULBP3. The cancer-associated Inhibitor of Apoptosis (IAP)-family protein is preferably a survivin protein or livin protein. Method of inhibiting tumor growth by administering the vaccine of the invention to a mammal is also described.

Abstract: The present invention relates to packaging material for contrast media and more specifically to packages comprising containers filled with contrast media and closed with a closure means. In particular, the invention relates to packaging material comprising closure means comprising Carbon Black. The invention further relates to methods for improving the stability of such contrast media during storage, and in particular the method includes filling the contrast media in a container and closing the container with a closure means comprising Carbon Black.

Abstract: Flexible package comprising a co-extruded multi-layer film with high amount of renewable material characterized by a high mechanical strength and which can be extruded with low complexity.

Abstract: Flexible package comprising a co-extruded multi-layer film with high amount of renewable material exhibiting good sliding and sealability properties.

Abstract: Packaging for prosthetic heart valves including an assembly for securely retaining a heart valve within a jar and facilitating retrieval therefrom. The assembly includes a packaging sleeve that fits closely within the jar and has a clip structure for securing a valve holder. Contrary to previous designs, in one embodiment the valve holder is directed downward into the jar, and the valve is retained with an inflow end upward. The valve may have flexible leaflets, and a leaflet parting member on the end of the shaft extends through the leaflets and couples with the valve holder. The assembly of the packaging sleeve, valve, and holder can then be removed from the jar and a valve delivery tube connected with the holder, or to the leaflet parting member. The packaging sleeve may be bifurcated into two halves connected at a living hinge to facilitate removal from around the valve/holder subassembly.

Abstract: A multi-container system apparatus comprising at least two independent containers, each container of said at least two containers for containing at least one component of the final formulation of a medium; a connector; a connecting tubing line connected to the connector; at least two output tubing lines, the first and second output tubing lines of said at least two output tubing lines connecting the first and second containers of said at least two containers, respectively, to the connecting tubing line.

Abstract: A pharmaceutical product includes a container having an exterior surface and an interior chamber, an active ingredient disposed in the interior chamber, the active ingredient having a photosensitive property that changes based on at least cumulative exposure to light having a wavelength within the range between X and Y, and a layer of photosensitive material disposed on or in the container and exposed to environmental conditions contemporaneous with the active ingredient being disposed in the interior chamber. The photosensitive material is reactive to light having a wavelength within the range between X and Y to experience a property change at a threshold of cumulative exposure to light received within the range between X and Y related to the change in the photosensitive property of the active ingredient. A photosensitive device can also be disposed along a path followed by the pharmaceutical product within a facility.

Abstract: The disclosure relates to volumetrically efficient systems for distributing, storing, and dispensing a number of medical or laboratory sharps with subsequent safe disposal of the used sharps. The systems comprise first and second sharps containers configured such that the combined containers, as well as contained sharps, may be shipped in a volume approximately equivalent to the volume of one of the containers.

Abstract: A packaging system for medical devices includes a elongate connector having a plurality of channels formed therein, and a first and a second tubular holder configured to form an assembly with an elongate, coiled medical device. The first and second tubular holders each have shapes congruous with the plurality of channels, and are positionable therein such that the elongate connector forms a bridge attaching the tubular holders in an assembly with a medical device.